title: HIV infection and specific mucosal immunity: workshop 4B.
abstract: Most HIV infections are transmitted across mucosal epithelium. An area of fundamental importance is understanding the role of innate and specific mucosal immunity in susceptibility or protection against HIV infection, as well as the effect of HIV infection on mucosal immunity, which leads to increased susceptibility to bacterial, fungal, and viral infections of oral and other mucosae. This workshop attempted to address 5 basic issues-namely, HIV acquisition across mucosal surfaces, innate and adaptive immunity in HIV resistance, antiviral activity of breast milk as a model mucosal fluid, neutralizing immunoglobulin A antibodies against HIV, and progress toward a mucosal vaccine against HIV. The workshop attendants agreed that progress had been made in each area covered, with much recent information. However, these advances revealed how little work had been performed on stratified squamous epithelium compared with columnar epithelium, and the attendants identified several important biological questions that had not been addressed. It is increasingly clear that innate immunity has an important biological role, although basic understanding of the mechanisms of normal homeostasis is still being investigated. Application of the emerging knowledge was lacking with regard to homeostatic mucosal immunity to HIV and its role in changing this homeostasis. With regard to breast milk, a series of studies have demonstrated the differences between transmitters and nontransmitters, although whether these findings could be generalized to other secretions such as saliva was less clear. Important progress toward an oral mucosal HIV vaccine has been made, demonstrating proof of principle for administering vaccine candidates into oral lymphoid tissues to trigger anti-HIV local and systemic immune responses. Similarly, experimental data emphasized the central role of neutralizing antibodies to prevent HIV infection via mucosal routes.
authors: Department of Oral Medicine, Kings College London Dental Institute, London, UK. stephen.challacombe@kcl.ac.uk
authors: S J
authors: SJ
authors: Challacombe
authors: P L
authors: PL
authors: Fidel
authors: S
authors: S
authors: Tugizov
authors: L
authors: L
authors: Tao
authors: S M
authors: SM
authors: Wahl
mesh_terms: D057134:Antibodies, Neutralizing / Q000502:physiology*; D004848:Epithelium / Q000276:immunology*; D017144:Focus Groups; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000032:analysis; D008895:Milk, Human / Q000276:immunology
chemical_list: D057134:Antibodies, Neutralizing; D007071:Immunoglobulin A, Secretory